Literature DB >> 1787946

Lacrimal obstruction after medial maxillectomy.

H J Glatt, A C Chan.   

Abstract

Medial maxillectomy can result in lacrimal obstruction and the need for subsequent dacryocystorhinostomy. Computed tomographic dacryocystography is a technique in which radiopaque dye is instilled in the lacrimal sac and computed tomography is subsequently performed. Computed tomographic dacryocystography facilitated the management of a patient with lacrimal obstruction after medial maxillectomy by helping to exclude recurrent tumor and sinusitis, and by providing a surgical "roadmap" in the presence of altered anatomy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1787946

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  5 in total

1.  Outcomes of endonasal endoscopic dacryocystorhinostomy after maxillectomy in patients with paranasal sinus and skull base tumors.

Authors:  Sara Abu-Ghanem; Ran Ben-Cnaan; Igal Leibovitch; Gilad Horowitz; Gadi Fishman; Dan M Fliss; Avraham Abergel
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-09-20       Impact factor: 2.503

2.  Outcomes of dacryocystorhinostomy in patients with head and neck cancer treated with high-dose radiation therapy.

Authors:  Tarek El-Sawy; Rasha Ali; Qasiem J Nasser; Bita Esmaeli
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2012 May-Jun       Impact factor: 1.746

3.  Imaging characteristics of dacryocystocele diagnosed after surgery for sinonasal cancer.

Authors:  J M Debnam; B Esmaeli; L E Ginsberg
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-05       Impact factor: 3.825

4.  Nasolacrimal Obstruction Following the Placement of Maxillofacial Hardware.

Authors:  J Minjy Kang; Evan Kalin-Hajdu; Oluwatobi O Idowu; M Reza Vagefi; Robert C Kersten
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2020-02-20

5.  Foreign body mimicking malignancy in acquired dacryocystocele.

Authors:  Ahmad A Mirza; Atheer F Alsharif; Omar A Elmays; Osama A Marglani
Journal:  Clin Case Rep       Date:  2017-02-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.